Your browser doesn't support javascript.
loading
New approaches to fetal growth restriction: the time for metabolomics has come / Novas abordagens para a restrição de crescimento fetal: é chegada a hora da metabolômica
Departament of Obstetrics and GynecologyLeite, Debora Farias Batista; Departament of Obstetrics and GynecologyCecatti, Jose Guilherme.
  • Departament of Obstetrics and GynecologyLeite, Debora Farias Batista; Universidade Estadual de Campinas. Faculdade de Ciências Médicas. Departament of Obstetrics and GynecologyLeite, Debora Farias Batista. Campinas. BR
  • Departament of Obstetrics and GynecologyCecatti, Jose Guilherme; Universidade Estadual de Campinas. Faculdade de Ciências Médicas. Departament of Obstetrics and GynecologyCecatti, Jose Guilherme. Campinas. BR
Rev. bras. ginecol. obstet ; 41(7): 454-462, July 2019. tab
Article in English | LILACS | ID: biblio-1020601
ABSTRACT
Abstract Fetal growth restriction (FGR) diagnosis is often made by fetal biometric ultrasound measurements orDoppler evaluation, but most babies are only diagnosed after birth, using the birth weight as a proxy for intrauterine development. The higher risks of neurodevelopmental delay, metabolic syndrome, and cardiovascular illness associated with FGR impose a shift on the focus during pregnancy. New methodological approaches, like metabolomics, can provide novel biomarkers for intrauterine fetal development. Recent evidence on metabolites involved with fetal growth and weight show a consistent role played by lipids (especially fatty acids), amino acids, vitamin D and folic acid. Fetal energy source andmetabolism, structural functions, and nervous system functioning need further evaluations in different populations. In the near future, the establishment of a core set of outcomes for FGR studies may improve the identification of the role of each metabolite in its development. Thus, we will concretely progress with the perspective of a translational capacity of metabolomics for this condition.
RESUMO
Resumo O diagnóstico da restrição do crescimento fetal (RCF) é frequentemente feito por medidas biométricas ultrassonográficas ou por avaliação pela Dopplervelocimetria, mas, na maioria dos casos, o diagnóstico é apenas pós-natal, usando o peso ao nascimento como um marcador para o desenvolvimento intrauterino. Riscos maiores de atraso do neurodesenvolvimento, síndrome metabólica e doenças cardiovasculares associadas com a RCF impõem uma mudança no foco durante a gestação. Novas abordagens metodológicas, como a metabolômica, podem fornecer novos biomarcadores para o desenvolvimento fetal intrauterino. As evidências recentes sobre os metabolitos envolvidos com o crescimento e peso fetalmostram um papel consistente desempenhado pelos lipídios (especialmente os ácidos graxos), aminoácidos, vitamina
Subject(s)


Full text: Available Index: LILACS (Americas) Main subject: Prenatal Diagnosis / Fetal Growth Retardation Type of study: Diagnostic study / Prognostic study Limits: Female / Humans / Pregnancy Language: English Journal: Rev. bras. ginecol. obstet Journal subject: Gynecology / Obstetrics Year: 2019 Type: Article Affiliation country: Brazil Institution/Affiliation country: Universidade Estadual de Campinas/BR

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Index: LILACS (Americas) Main subject: Prenatal Diagnosis / Fetal Growth Retardation Type of study: Diagnostic study / Prognostic study Limits: Female / Humans / Pregnancy Language: English Journal: Rev. bras. ginecol. obstet Journal subject: Gynecology / Obstetrics Year: 2019 Type: Article Affiliation country: Brazil Institution/Affiliation country: Universidade Estadual de Campinas/BR